我的风湿性疾病患者感染新冠病毒的风险更高吗？ - Suppr

Are my patients with rheumatic diseases at higher risk of COVID-19?

作者信息

Figueroa-Parra Gabriel, Aguirre-Garcia Gloria Mayela, Gamboa-Alonso Carmen Magdalena, Camacho-Ortiz Adrian, Galarza-Delgado Dionicio Angel

机构信息

Servicio de Reumatología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.

Servicio de Infectología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.

出版信息

Ann Rheum Dis. 2020 Jun;79(6):839-840. doi: 10.1136/annrheumdis-2020-217322. Epub 2020 Mar 22.

DOI:10.1136/annrheumdis-2020-217322

PMID:32205336

Abstract

摘要

相似文献

Are my patients with rheumatic diseases at higher risk of COVID-19?我的风湿性疾病患者感染新冠病毒的风险更高吗？

Ann Rheum Dis. 2020 Jun;79(6):839-840. doi: 10.1136/annrheumdis-2020-217322. Epub 2020 Mar 22.

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.慢性炎症和自身免疫性风湿病患者中经医院聚合酶链反应（PCR）确诊的 COVID-19 病例的流行情况。

Ann Rheum Dis. 2020 Sep;79(9):1170-1173. doi: 10.1136/annrheumdis-2020-217763. Epub 2020 Jun 12.

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.如何在 COVID-19 时代处理自身免疫性风湿和炎症性肠病患者：专家意见。

Autoimmun Rev. 2020 Jul;19(7):102574. doi: 10.1016/j.autrev.2020.102574. Epub 2020 May 5.

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.德国炎症性风湿病（IRD）患者感染 SARS-CoV-2 的国家登记处（ReCoVery）：了解 IRD 患者 SARS-CoV-2 感染临床病程的快速可靠知识的宝贵手段。

RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2020-001332.

COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.COVID-19 与风湿性自身免疫性系统性疾病：一项大型意大利患者系列报告。

Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.2019年冠状病毒病（COVID-19）与抗风湿药物

Rheumatol Int. 2020 May;40(5):825-826. doi: 10.1007/s00296-020-04570-z. Epub 2020 Mar 30.

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者因 COVID-19 住院的相关特征：来自 COVID-19 全球风湿病联盟医生报告登记处的数据。

Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29.

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.接受生物和合成靶向治疗的风湿性疾病患者中COVID-19的临床特征和结局

Ann Rheum Dis. 2020 Jul;79(7):988-990. doi: 10.1136/annrheumdis-2020-217948. Epub 2020 Jun 5.

Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.COVID-19 相关住院风险因素在自身免疫性炎症性风湿病患者中的分析。

Ann Rheum Dis. 2020 Nov;79(11):1393-1399. doi: 10.1136/annrheumdis-2020-217984. Epub 2020 Aug 7.

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.德国风湿病学会（DGRh eV）关于SARS-CoV-2/COVID-19大流行期间炎性风湿性疾病患者管理的初步建议。

Ann Rheum Dis. 2020 Jun;79(6):840-842. doi: 10.1136/annrheumdis-2020-217628. Epub 2020 Apr 28.

引用本文的文献

[Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion].[COVID-19 健康紧急状态下风湿病学家药物治疗管理建议：专家组意见]

Rev Colomb Reumatol. 2021 Apr-Jun;28(2):134-140. doi: 10.1016/j.rcreu.2020.05.021. Epub 2020 Jun 26.

Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases.伊朗风湿性疾病患者中2019冠状病毒病（COVID-19）感染的频率、特征及结果

Egypt Rheumatol. 2022 Jun;44(3):209-213. doi: 10.1016/j.ejr.2021.12.002. Epub 2021 Dec 10.

Coronavirus Disease 2019 in Rheumatic Patients with Inflammatory Disorders: A Descriptive Study from a High Infection Incidence Region of Northern Spain.西班牙北部高感染率地区炎症性疾病风湿患者的2019冠状病毒病：一项描述性研究

Eur J Rheumatol. 2023 Oct;10(4):136-142. doi: 10.5152/eurjrheum.2023.21152.

The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases.中国在奥密克戎变异株占主导期间新冠病毒疾病的近期暴发：自身免疫性炎性风湿性疾病患者的临床特征及转归

Rheumatol Ther. 2023 Aug;10(4):1039-1053. doi: 10.1007/s40744-023-00569-7. Epub 2023 Jun 19.

Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.固有免疫和适应性免疫对 SARS-CoV-2 及相关影响因素。

Front Immunol. 2023 May 9;14:1159326. doi: 10.3389/fimmu.2023.1159326. eCollection 2023.

Comparison of Clinical Characteristics and Outcomes of Hospitalized Patients Infected with the D614G Strain or Alpha Variant of COVID-19 in Taiwan: A Multi-Center Cohort Study.台湾地区感染 D614G 株或 Alpha 变异株的 COVID-19 住院患者的临床特征和结局比较：一项多中心队列研究。

Int J Med Sci. 2022 Oct 24;19(13):1912-1919. doi: 10.7150/ijms.76725. eCollection 2022.

Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review.合并症、相关疾病和 COVID-19 风险评估——系统综述。

Int J Clin Pract. 2022 Oct 31;2022:1571826. doi: 10.1155/2022/1571826. eCollection 2022.

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study.类风湿关节炎及其表型亚组与重症 COVID-19 结局的相关性：一项回顾性、比较性、多中心队列研究。

Lancet Rheumatol. 2022 Nov;4(11):e765-e774. doi: 10.1016/S2665-9913(22)00227-2. Epub 2022 Sep 13.

Outcomes of COVID-19 in Inflammatory Rheumatic Diseases: A Retrospective Cohort Study.炎症性风湿疾病中新冠病毒病的结局：一项回顾性队列研究

Cureus. 2022 Jun 26;14(6):e26343. doi: 10.7759/cureus.26343. eCollection 2022 Jun.

Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?新冠疫情期间的乳糜泻：HLA 具有保护作用吗？

Ann Med. 2022 Dec;54(1):617-621. doi: 10.1080/07853890.2022.2039955.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Are my patients with rheumatic diseases at higher risk of COVID-19?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献